9-133351945-T-TA
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_003172.4(SURF1):c.870_871insT(p.Lys291Ter) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000753 in 1,461,620 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000075 ( 0 hom. )
Consequence
SURF1
NM_003172.4 frameshift
NM_003172.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.396
Genes affected
SURF1 (HGNC:11474): (SURF1 cytochrome c oxidase assembly factor) This gene encodes a protein localized to the inner mitochondrial membrane and thought to be involved in the biogenesis of the cytochrome c oxidase complex. The protein is a member of the SURF1 family, which includes the related yeast protein SHY1 and rickettsial protein RP733. The gene is located in the surfeit gene cluster, a group of very tightly linked genes that do not share sequence similarity, where it shares a bidirectional promoter with SURF2 on the opposite strand. Defects in this gene are a cause of Leigh syndrome, a severe neurological disorder that is commonly associated with systemic cytochrome c oxidase deficiency. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0365 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 9-133351945-T-TA is Pathogenic according to our data. Variant chr9-133351945-T-TA is described in ClinVar as [Pathogenic]. Clinvar id is 520829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SURF1 | NM_003172.4 | c.870_871insT | p.Lys291Ter | frameshift_variant | 9/9 | ENST00000371974.8 | NP_003163.1 | |
SURF1 | NM_001280787.1 | c.543_544insT | p.Lys182Ter | frameshift_variant | 8/8 | NP_001267716.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SURF1 | ENST00000371974.8 | c.870_871insT | p.Lys291Ter | frameshift_variant | 9/9 | 1 | NM_003172.4 | ENSP00000361042 | P1 | |
SURF1 | ENST00000615505.4 | c.543_544insT | p.Lys182Ter | frameshift_variant | 8/8 | 1 | ENSP00000482067 | |||
SURF1 | ENST00000437995.1 | n.780_781insT | non_coding_transcript_exon_variant | 8/8 | 5 | |||||
SURF1 | ENST00000495952.5 | n.860_861insT | non_coding_transcript_exon_variant | 5/5 | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250790Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135676
GnomAD3 exomes
AF:
AC:
1
AN:
250790
Hom.:
AF XY:
AC XY:
0
AN XY:
135676
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461620Hom.: 0 Cov.: 33 AF XY: 0.00000138 AC XY: 1AN XY: 727076
GnomAD4 exome
AF:
AC:
11
AN:
1461620
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
727076
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Mitochondrial complex IV deficiency, nuclear type 1 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 1998 | - - |
Leigh syndrome Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 09, 2023 | Variant summary: SURF1 c.870dupT (p.Lys291X) results in a premature termination codon, predicted to cause a truncation of the encoded protein, which is a commonly known mechanism for disease. The variant allele was found at a frequency of 4e-06 in 250790 control chromosomes (gnomAD). c.870dupT has been reported in the literature as a biallelic genotype in multiple individuals affected with Leigh Syndrome (e.g. Tiranti_1998, Ribeiro_2016, Kose_2020). These data indicate that the variant is very likely to be associated with disease. Experimental evidence evaluating an impact of the variant on protein function found that COX levels in homozygous tissues were 10%-15% of normal (Tiranti_1998, Tiranti_1999). Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and both classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 05, 2023 | This variant is present in population databases (rs782061187, gnomAD 0.003%). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 520829). This variant is also known as c.868_869insT, 868insT, K290X. This premature translational stop signal has been observed in individual(s) with clinical features of mitochondrial complex IV deficiency (PMID: 9837813, 25111564, 27756633). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This sequence change creates a premature translational stop signal (p.Lys291*) in the SURF1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 10 amino acid(s) of the SURF1 protein. - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2015 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at